decabromobiphenyl ether has been researched along with Chemical and Drug Induced Liver Injury in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 5 (71.43) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, L; Ge, W; Jing, L; Li, X; Liu, S; Sang, Y; Shi, Z; Sun, Z; Zhang, Y; Zhou, G; Zhou, X; Zhu, Y | 1 |
| Dang, C; Fu, J; Lu, B; Luo, Y; Wang, Y; Yang, Y | 1 |
| Gao, L; Li, X; Wang, Y; Xue, J; Zhang, Y; Zhao, D; Zhao, M; Zhou, X | 1 |
| Jin, Y; Rao, Q; Yang, J; Yang, Y; Zhao, Z; Zhu, X | 1 |
| Chen, T; Jing, L; Liang, B; Shi, Z; Sun, Y; Sun, Z; Wang, Y; Zhao, X; Zheng, D; Zhou, X | 1 |
| Faiola, F; Liang, S; Yin, N | 1 |
| Antonijević, B; Antunović, M; Ćurčić, M; Djordjević, S; Janković, S; Kilibarda, V; Stanković, S; Tanasković, S; Vučnić, S | 1 |
7 other study(ies) available for decabromobiphenyl ether and Chemical and Drug Induced Liver Injury
| Article | Year |
|---|---|
Decabromodiphenyl ether-induced PRKACA hypermethylation contributed to glycolipid metabolism disorder via regulating PKA/AMPK pathway in rat and L-02 cells.
Topics: AMP-Activated Protein Kinases; Animals; Blood Glucose; Cell Line; Chemical and Drug Induced Liver Injury; Cholesterol; Cyclic AMP-Dependent Protein Kinase Catalytic Subunits; Glycolipids; Halogenated Diphenyl Ethers; Humans; Liver; Male; Protein Kinases; Rats, Sprague-Dawley; Signal Transduction; Triglycerides | 2022 |
Is it really safe to replace decabromodiphenyl ether (BDE209) with decabromodiphenyl ethane (DBDPE)?: A perspective from hepatotoxicity.
Topics: Benzene; Bromobenzenes; Chemical and Drug Induced Liver Injury; Dioxins; Flame Retardants; Halogenated Diphenyl Ethers; Humans | 2023 |
Ferroptosis mediates decabromodiphenyl ether-induced liver damage and inflammation.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cytokines; Ferroptosis; Inflammation; Mice; Mice, Inbred ICR; NF-kappa B | 2023 |
Hepatotoxicity evaluation and possible mechanisms of decabrominated diphenyl ethers (BDE-209) in broilers: Oxidative stress, inflammatory, and transcriptomics.
Topics: Animals; Chemical and Drug Induced Liver Injury; Chickens; Cytokines; Halogenated Diphenyl Ethers; Inflammation; Male; Oxidative Stress; Transcriptome | 2023 |
Hepatotoxicity of decabromodiphenyl ethane (DBDPE) and decabromodiphenyl ether (BDE-209) in 28-day exposed Sprague-Dawley rats.
Topics: Animals; Bromobenzenes; Chemical and Drug Induced Liver Injury; Flame Retardants; Halogenated Diphenyl Ethers; Rats; Rats, Sprague-Dawley | 2020 |
Establishment of a human embryonic stem cell-based liver differentiation model for hepatotoxicity evaluations.
Topics: Animals; Cell Differentiation; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Embryonic Development; Endocrine Disruptors; Environmental Pollutants; Female; Halogenated Diphenyl Ethers; Hepatocytes; Human Embryonic Stem Cells; Humans; Models, Biological; Pregnancy; Thyroxine; Transcriptome; Triiodothyronine | 2019 |
Relationship of hepatotoxicity and the target tissue dose of decabrominated diphenyl ether in subacutely exposed Wistar rats.
Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; gamma-Glutamyltransferase; Halogenated Diphenyl Ethers; Liver; Malondialdehyde; Oxidative Stress; Rats; Rats, Wistar; Superoxide Dismutase | 2015 |